Geneos Wealth Management’s AllianzIM U.S. Equity Buffer20 Sep ETF SEPW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.2K Hold
482
﹤0.01% 1865
2025
Q4
$15.4K Sell
482
-2,284
-83% -$72.1K ﹤0.01% 1827
2025
Q3
$86.9K Buy
2,766
+766
+38% +$23.6K ﹤0.01% 1167
2025
Q2
$60.3K Sell
2,000
-2,000
-50% -$57.9K ﹤0.01% 1470
2025
Q1
$114K Buy
4,000
+3,000
+300% +$87.1K ﹤0.01% 1498
2024
Q4
$28.9K Buy
+1,000
New +$28.8K ﹤0.01% 1560

Other funds holding SEPW

Geneos Wealth Management's SEPW Position: Q1 2026 in Review

Geneos Wealth Management held its AllianzIM U.S. Equity Buffer20 Sep ETF (SEPW) position steady in Q1 2026 at 482 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1865.

Geneos Wealth Management first reported a position in SEPW in Q4 2024 and has held it in 6 quarters since. The position peaked at $114K in Q1 2025. 65 funds tracked by Wall St. Rank hold SEPW as of Q1 2026.

  • Geneos Wealth Management held 482 shares of AllianzIM U.S. Equity Buffer20 Sep ETF worth $15.2K as of Q1 2026.
  • Geneos Wealth Management left its AllianzIM U.S. Equity Buffer20 Sep ETF share count unchanged in Q1 2026.
  • AllianzIM U.S. Equity Buffer20 Sep ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1865 holding.
  • Geneos Wealth Management first reported a position in AllianzIM U.S. Equity Buffer20 Sep ETF in Q4 2024 and has held it in 6 quarters since.
  • Geneos Wealth Management's AllianzIM U.S. Equity Buffer20 Sep ETF position peaked at $114K in Q1 2025.
  • 65 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer20 Sep ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.